Contribution of renal impairment to potentially preventable medication-related hospital admissions

The Annals of Pharmacotherapy
A J LeendertseP M L A van den Bemt

Abstract

Medication errors and renal impairment contribute to severe adverse drug events, which may lead to hospital admission. To determine whether medication errors and renal impairment contribute to hospital admission and examine these errors for strategies to prevent admissions. The 714 medication-related hospital admissions reported in the prospective multicenter study HARM (Hospital Admissions Related to Medication) were analyzed. The patients were divided into 3 groups based on the availability of creatinine levels: group A, the home-monitored group (n = 227); group B, the hospital-monitored group (n = 420); and group C, the unmonitored group (n = 67). After assessment, 70 admissions (10%) were considered to be related to a medication error and renal impairment (A, 29; B, 41; C, none). In these 70 patients, 85 errors occurred in group A, 66 errors in group B, and none in group C. Dosing errors were identified in 46 patients (A, 14; B, 32), a drug-drug interaction in 22 patients (A, 13; B, 9), and a drug-disease interaction in 17 patients (A, 10; B, 7). Renal impairment and medication errors may lead to medication-related hospital admissions. Monitoring renal function and adjusting pharmacotherapy according to renal function might...Continue Reading

References

Oct 1, 1973·Annals of Internal Medicine·R W Jelliffe
Sep 1, 1980·The American Journal of Psychiatry·R B StewartJ E Adams
Jan 22, 1997·JAMA : the Journal of the American Medical Association·D C ClassenJ P Burke
Jan 22, 1997·JAMA : the Journal of the American Medical Association·T S LesarD S Stein
Jan 1, 1997·Journal of Clinical Epidemiology·J F Steiner, A V Prochazka
Nov 4, 1998·Postgraduate Medical Journal·N A Wong, H W Jones
Nov 18, 2000·Journal of the American Geriatrics Society·A PapaioannouM Bédard
May 1, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·L DuncanA Levin
Jun 26, 2001·Journal of General Internal Medicine·A D FalconnierM Martin-Facklam
Sep 26, 2001·The American Journal of the Medical Sciences·K T HuF T Stevenson
Dec 12, 2001·JAMA : the Journal of the American Medical Association·G M ChertowD W Bates
Aug 28, 2002·The Annals of Pharmacotherapy·Patrick J McDonnell, Michael R Jacobs
Dec 25, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Josef CoreshAndrew S Levey
Jun 24, 2003·Journal of the American Society of Nephrology : JASN·Steven J ChadbanRobert C Atkins
Aug 22, 2003·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·L SalomonP Ravaud
Apr 27, 2005·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Ira S NashMark R Chassin
Jun 29, 2006·The Annals of Pharmacotherapy·Elisabeth A van DijkPeter A G M De Smet
Mar 27, 2007·Journal of Clinical Pharmacy and Therapeutics·J IndermitteK E Hersberger
Nov 8, 2007·JAMA : the Journal of the American Medical Association·Josef CoreshAndrew S Levey
Mar 15, 2008·Pharmacoepidemiology and Drug Safety·Jasperien E van DoormaalFlora M Haaijer-Ruskamp
Apr 15, 2008·BMC Public Health·Qiu-Li Zhang, Dietrich Rothenbacher
Apr 14, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Theresa HahnPhilip L McCarthy
Apr 25, 2009·Journal of the American Medical Informatics Association : JAMIA·Terry S FieldJerry H Gurwitz
Dec 10, 2009·JAMA : the Journal of the American Medical Association·Thomas T TsaiUNKNOWN National Cardiovascular Data Registry
Feb 8, 2011·Theriogenology·J MustersA C Okkens

❮ Previous
Next ❯

Citations

Jul 9, 2014·Journal of General Internal Medicine·Michael A SteinmanJanice B Schwartz
Jan 1, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Fabio SalviAntonio Cherubini
Oct 28, 2015·Journal of the American Geriatrics Society·Flora ChangMichael A Steinman
Jul 3, 2013·Journal of Clinical Pharmacy and Therapeutics·A F J GeertsW W van Solinge
Apr 25, 2015·Journal of Evaluation in Clinical Practice·Thibaut CarubaBrigitte Sabatier
Jun 17, 2016·International Journal of Clinical Pharmacy·Ellen S KosterMarcel L Bouvy
Feb 28, 2019·BMJ : British Medical Journal·David Oliver
Feb 21, 2019·BMJ : British Medical Journal·David Oliver
Aug 29, 2016·European Journal of Clinical Pharmacology·Willemijn L EppengaPeter A G M De Smet
Sep 4, 2018·Applied Health Economics and Health Policy·Judith J Gout-ZwartMaarten J Postma
Oct 30, 2020·European Journal of Hospital Pharmacy. Science and Practice·Mesut SancarBetul Okuyan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.